封面
市场调查报告书
商品编码
1732824

细胞和基因疗法生物分析测试服务市场—全球产业规模、份额、趋势、机会和预测,按测试类型、产品类型、开发阶段、适应症、地区和竞争细分,2020 年至 2030 年

Cell & Gene Therapy Bioanalytical Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Product Type, By Stage of Development, By Indication, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球细胞和基因治疗生物分析测试服务市值为 5.2326 亿美元,预计到 2030 年将达到 8.7029 亿美元,预测期内复合年增长率为 8.85%。细胞和基因治疗领域不断扩大,透过提供个人化、有针对性的治疗,彻底改变了遗传和慢性疾病的治疗方法。随着这些疗法从研究走向商业化,对精确且合规的生物分析测试服务的需求正在显着增长。这些服务对于确保安全性、有效性和品质符合不断变化的监管要求至关重要。支持性资金、技术创新和不断扩大的治疗管道正在加速市场发展,而业界对客製化治疗解决方案的日益重视不断提升生物分析测试在细胞和基因治疗生命週期中的作用。

市场概览
预测期 2026-2030
2024年市场规模 5.2326亿美元
2030年市场规模 8.7029亿美元
2025-2030 年复合年增长率 8.85%
成长最快的领域 肿瘤学
最大的市场 北美洲

关键市场驱动因素

增加细胞和基因治疗研发的投资

主要市场挑战

监管挑战

主要市场趋势

技术进步

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球细胞与基因治疗生物分析测试服务市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按测试类型(生物利用度和生物等效性研究、药物动力学、药效学、其他测试类型)
    • 依产品类型(基因疗法、基因修饰细胞疗法、细胞疗法)
    • 依开发阶段(非临床、临床)
    • 依适应症(肿瘤科、传染病科、神经系统疾病科、罕见疾病科、其他科)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第六章:北美细胞与基因治疗生物分析测试服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲细胞与基因治疗生物分析测试服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章:亚太细胞与基因治疗生物分析测试服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美洲细胞与基因治疗生物分析测试服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东和非洲细胞和基因治疗生物分析测试服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 合併与收购
  • 产品开发
  • 最新动态

第 13 章:全球细胞和基因治疗生物分析测试服务市场:SWOT 分析

第 14 章:竞争格局

  • BioAgilytix Labs Inc.
  • KCAS Bioanalytical & Biomarker Services
  • IQVIA, Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.
  • Prolytix pvt ltd
  • Pharmaron Biologics (UK) Ltd
  • Charles River Laboratories International, Inc.
  • Syneos Health Ltd
  • Intertek Group Plc

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 16278

The Global Cell & Gene Therapy Bioanalytical Testing Services Market was valued at USD 523.26 million in 2024 and is expected to reach USD 870.29 million by 2030, growing at a CAGR of 8.85% during the forecast period. The expanding field of cell and gene therapy is revolutionizing treatment approaches for genetic and chronic diseases by offering personalized, targeted therapies. As these therapies progress from research to commercialization, the demand for precise and compliant bioanalytical testing services is growing significantly. These services are critical for ensuring safety, efficacy, and quality in line with evolving regulatory expectations. Supportive funding, technological innovations, and the expanding therapeutic pipeline are accelerating market development, while growing industry emphasis on tailored treatment solutions continues to elevate the role of bioanalytical testing in the cell and gene therapy lifecycle.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 523.26 Million
Market Size 2030USD 870.29 Million
CAGR 2025-20308.85%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

Increasing Investment in Cell and Gene Therapy Research and Development

Recent breakthroughs in cell and gene therapy have opened new possibilities for treating diseases previously deemed untreatable. These treatments work by altering patients' own cells or genes to address conditions such as cancer, autoimmune disorders, and genetic abnormalities. As the clinical potential of these therapies becomes more evident, global investment in research and development has increased rapidly. Bioanalytical testing services play an essential role in this growth by ensuring product safety, efficacy, and consistency. Notably, in April 2023, the California Institute for Regenerative Medicine committed USD 89.0 million toward advancing gene and stem cell research, exemplifying the growing commitment to innovation in this space.

Key Market Challenges

Regulatory Challenges

Navigating regulatory frameworks remains one of the most pressing challenges in the cell and gene therapy bioanalytical testing market. Regulatory agencies are continuously updating standards to ensure patient safety while accommodating rapid technological advances. This dynamic landscape makes compliance a complex and time-consuming process. Companies often face delays and increased costs when attempting to align with these evolving guidelines, which can hinder the pace of therapy development and market entry. Meeting global regulatory expectations while innovating at speed demands significant investment and specialized expertise.

Key Market Trends

Technological Advancements

As cell and gene therapies reshape modern medicine, the bioanalytical testing segment is advancing rapidly to meet new analytical demands. A major trend is the integration of single-cell analysis technologies, including single-cell RNA sequencing and proteomics, which allow deeper insights into cellular responses and therapeutic outcomes. These methods address the limitations of traditional bulk analysis by revealing intercellular variability. Another transformative trend is the adoption of CRISPR-Cas9, a powerful gene-editing tool that demands specialized testing protocols to evaluate gene function and detect potential off-target effects. Furthermore, the deployment of state-of-the-art instrumentation has enhanced the precision and speed of testing processes, enabling faster and more accurate evaluation of complex therapies and supporting the broader growth of the market.

Key Market Players

  • BioAgilytix Labs Inc.
  • KCAS Bioanalytical & Biomarker Services
  • IQVIA, Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.
  • Prolytix pvt ltd
  • Pharmaron Biologics (UK) Ltd
  • Charles River Laboratories International, Inc.
  • Syneos Health Ltd
  • Intertek Group Plc

Report Scope:

In this report, the Global Cell & Gene Therapy Bioanalytical Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type:

  • Bioavailability & Bioequivalence Studies
  • Pharmacokinetics
  • Pharmacodynamics
  • Other test type

Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type:

  • Gene Therapy
  • Gene-Modified Cell Therapy
  • Cell Therapy

Cell & Gene Therapy Bioanalytical Testing Services Market, By Stage of Development:

  • Non-Clinical
  • Clinical

Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication:

  • Oncology
  • Infectious Diseases
  • Neurological disorders
  • Rare Diseases
  • Others

Cell & Gene Therapy Bioanalytical Testing Services Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell & Gene Therapy Bioanalytical Testing Services Market.

Available Customizations:

Global Cell & Gene Therapy Bioanalytical Testing Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test Type)
    • 5.2.2. By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy)
    • 5.2.3. By Stage of Development (Non-Clinical, Clinical)
    • 5.2.4. By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Product Type
    • 6.2.3. By Stage of Development
    • 6.2.4. By Indication
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Stage of Development
        • 6.3.1.2.4. By Indication
    • 6.3.2. Canada Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Stage of Development
        • 6.3.2.2.4. By Indication
    • 6.3.3. Mexico Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Stage of Development
        • 6.3.3.2.4. By Indication

7. Europe Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Product Type
    • 7.2.3. By Stage of Development
    • 7.2.4. By Indication
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Stage of Development
        • 7.3.1.2.4. By Indication
    • 7.3.2. United Kingdom Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Stage of Development
        • 7.3.2.2.4. By Indication
    • 7.3.3. Italy Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Stage of Development
        • 7.3.3.2.4. By Indication
    • 7.3.4. France Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Stage of Development
        • 7.3.4.2.4. By Indication
    • 7.3.5. Spain Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Stage of Development
        • 7.3.5.2.4. By Indication

8. Asia-Pacific Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Product Type
    • 8.2.3. By Stage of Development
    • 8.2.4. By Indication
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Stage of Development
        • 8.3.1.2.4. By Indication
    • 8.3.2. India Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Stage of Development
        • 8.3.2.2.4. By Indication
    • 8.3.3. Japan Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Stage of Development
        • 8.3.3.2.4. By Indication
    • 8.3.4. South Korea Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Stage of Development
        • 8.3.4.2.4. By Indication
    • 8.3.5. Australia Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Stage of Development
        • 8.3.5.2.4. By Indication

9. South America Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Product Type
    • 9.2.3. By Stage of Development
    • 9.2.4. By Indication
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Stage of Development
        • 9.3.1.2.4. By Indication
    • 9.3.2. Argentina Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Stage of Development
        • 9.3.2.2.4. By Indication
    • 9.3.3. Colombia Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Stage of Development
        • 9.3.3.2.4. By Indication

10. Middle East and Africa Cell & Gene Therapy Bioanalytical Testing Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Product Type
    • 10.2.3. By Stage of Development
    • 10.2.4. By Indication
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Stage of Development
        • 10.3.1.2.4. By Indication
    • 10.3.2. Saudi Arabia Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Stage of Development
        • 10.3.2.2.4. By Indication
    • 10.3.3. UAE Cell & Gene Therapy Bioanalytical Testing Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Stage of Development
        • 10.3.3.2.4. By Indication

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition
  • 12.2. Product Development
  • 12.3. Recent Developments

13. Global Cell & Gene Therapy Bioanalytical Testing Services Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. BioAgilytix Labs Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. KCAS Bioanalytical & Biomarker Services
  • 14.3. IQVIA, Inc.
  • 14.4. Laboratory Corporation of America Holdings
  • 14.5. Thermo Fisher Scientific Inc.
  • 14.6. Prolytix pvt ltd
  • 14.7. Pharmaron Biologics (UK) Ltd
  • 14.8. Charles River Laboratories International, Inc.
  • 14.9. Syneos Health Ltd
  • 14.10. Intertek Group Plc

15. Strategic Recommendations

16. About Us & Disclaimer